← 返回首页
美国 · 平台与数据 · Seeking Alpha

Ideaya picks cancer drug candidate, targets human trial application in 2027

来源:Seeking Alpha · 美国 21 分钟前
Phynart Studio
Phynart Studio · Seeking Alpha

详细摘要

Ideaya Biosciences selects IDE101, a preclinical drug candidate for cancers lacking CDKN2A, and aims to seek U.S.

Ideaya Biosciences (IDYA) on Sunday said it selected IDE101 as a drug candidate for further development to treat cancers lacking CDKN2A, a gene that normally helps prevent uncontrolled cell growth. The company aims to seek U.S. regulatory permission to begin human testing

文章开头,摘自Seeking Alpha。如需阅读全文,请前往媒体网站。

在 Seeking Alpha 阅读全文 登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (seekingalpha.com)

推荐阅读